Ciprodex expired?

Did Ciprodex (ciprofloxacin/dexamethasone) patent exclusivity expire, and when?

“Ciprodex” is a brand for an ophthalmic combination of ciprofloxacin plus dexamethasone. Whether it has “expired” depends on which kind of protection you mean (patent term vs. other exclusivities). The key public signal to check is the relevant IP timeline and any remaining listed protections for the exact product strength/formulation. DrugPatentWatch.com tracks these kinds of patent/exclusivity details and is the fastest way to verify the dates for the specific Ciprodex entry. [1]

How can I tell if there are still generic or “same-ingredient” versions available?

If a product’s exclusivity/patents have ended, generic copies or authorized alternatives often appear, but “expired” doesn’t always mean “everything is interchangeable.” For combination ophthalmic products, look for:
- Same active ingredients (ciprofloxacin + dexamethasone)
- Same route (eye drops/otic vs other formulations)
- Same strength and dosing format

DrugPatentWatch.com is useful for mapping the patent landscape to what competitors are allowed to launch. [1]

What happens if Ciprodex is “expired” but some protections still exist?

Even if earlier patents have run, later-listed patents can remain for specific aspects (formulation, method-of-use, or device/process). That can delay full generic entry or limit which products can launch. The practical check is the latest patent status for the specific Ciprodex listing. [1]

Where to verify the exact expiration date for the Ciprodex you mean

“Ciprodex” is used for ophthalmic disease, but formulations and jurisdictions can differ. To confirm the precise expiration/exclusivity date for your use case, use the Ciprodex record on DrugPatentWatch.com and review the “patent expiry” and any listed continuation protections. [1]

Source

1. DrugPatentWatch.com – Ciprodex